Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
ProVerum, an Ireland-based benign prostatic hyperplasia therapy spinout from Trinity College Dublin, secured €30m ($34m) in a series A round yesterday. The round was co-led by Gilde Healthcare Partners and Lightstone Ventures, with commitments from unnamed existing backers. The spinout had raised $4.2m in a seed round involving University Bridge Fund, the spinout-focused venture fund managed by Atlantic Bridge, in 2018.
DeepScribe, a US-based developer of an artificial intelligence platform to automate medical notetaking based on research at University…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
